Home / Dexamethasone / United States
US ATC H02AB02 · updated 2 Nov 2026
Dexamethasone shortage in United States
Is there a Dexamethasone shortage in United States?
Yes. As of 2 Nov 2026, 2 Dexamethasone products are reported short in United States, the first since 8 Feb 2019. No return date has been given. Main reason: increased demand.
Also short in Canada, Germany, France, Italy, Austria, Belgium, Switzerland, Sweden, Australia. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-0212-10) | Fresenius Kabi USA, LLC | 8 Feb 2019 | not given | Increased demand Demand increase for the drug |
| US | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-0210-10) | Fresenius Kabi USA, LLC | 8 Feb 2019 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).